Learn how to market with the modern consumer’s wants and needs in mind at Commerceweek, July 11–12, with brand leaders from Visa, Uber, TikTok and more. Sign up now to save 35%.
Earlier this month, David Bronner, CEO of soap brand Dr. Bronner’s, was hopping a short flight from Southern California up to Portland. As a dedicated supporter of Oregon Measure 109—which would legalize psilocybin-producing mushrooms for therapeutic use—Bronner wanted to be on hand for the ballot initiative’s historic passage.
As the chief of a cultishly popular boutique skincare brand known as much for its castile soap as for its political activism, Bronner was also excited to have filled his carry-on bag with some samples of his latest product: a limited-edition bar of soap that, so far as anyone knows, is an industry first.